Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07173478
PHASE3
A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis
Sponsor: Otsuka Pharmaceutical Co., Ltd.
View on ClinicalTrials.gov
Summary
To investigate the superiority of 1% OPA-15406 foam to the vehicle in adult patients with atopic dermatitis (AD).
Official title: A Multicenter, Randomized, Double-blind, Vehicle-controlled, Parallel-group Comparison Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis (Phase 3 Trial)
Key Details
Gender
All
Age Range
15 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
156
Start Date
2025-10
Completion Date
2026-12
Last Updated
2025-09-15
Healthy Volunteers
No
Conditions
Interventions
DRUG
OPA-15406
1% foam, topical, twice daily, for 4 weeks
DRUG
Vehicle
vehicle, topical, twice daily, for 4 weeks
Locations (1)
Mita Dermatology Clinic
Tokyo, Japan